Volume | 0 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
AnPac Bio Medical Science Company Ltd | ANPC | NASDAQ | Depository Receipt |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
4.37 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 4.37 | USD |
AnPac Bio Medical Science Company Ltd Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
48.95M | - | - | - | 2,297.99 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News AnPac Bio Medical Science
Date | Time | Source | Heading |
---|---|---|---|
4/02/2024 | 15:23 | Edgar (US Regulatory) | Form 8-K - Current report |
4/02/2024 | 08:01 | Edgar (US Regulatory) | Form NT 10-K - Notification of inability to timely file Form.. |
3/27/2024 | 15:12 | Edgar (US Regulatory) | Form 8-K - Current report |
3/25/2024 | 15:06 | Edgar (US Regulatory) | Form 8-K - Current report |
3/25/2024 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
3/25/2024 | 15:02 | Edgar (US Regulatory) | Form 20-F/A - Annual and transition report of foreign.. |
5/19/2023 | 11:55 | PR Newswire (US) | Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from.. |
5/16/2023 | 16:00 | PR Newswire (US) | Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022 |
5/16/2023 | 15:15 | PR Newswire (US) | Fresh2 Reports First Quarter of Fiscal Year 2023 Financial.. |
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
ANPC Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
AnPac Bio-Medical Science Co Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis and recurrence. |